Share

The effect of pulsed electromagnetic field on patients with endocrine ophthalmopathy.

J Jankauskiene, A Paunksnis, A Bluziene, J Saulgozis

PAPERpubmedEuropean journal of ophthalmology1998OtherEffect: mixedEvidence: Very low

Abstract

PURPOSE: To evaluate eye signs, proptosis and ocular movements in patients with endocrine ophthalmopathy under the influence of pulsed electromagnetic field therapy. METHODS: We examined 14 patients (9 women, 5 men) with endocrine ophthalmopathy and evaluated eye signs, proptosis and ocular movements before and after the course of pulsed electromagnetic field therapy, and 12 controls. Their age ranged from 29 to 57 years. Visual sensitivity was investigated with a static automatic perimeter (Allergan Humphrey Field Analyzer). The score was calculated by rating the severity of involvement of soft tissue, proptosis, extraocular movements, corneal state and optic nerve function on a scale from 0 to 3. The pulsed electromagnetic field procedures were carried out with the help of electromagnetic spectacles. RESULTS: Pulsed electromagnetic field therapy reduced the score for soft tissue and proptosis in patients who suffered from endocrine ophthalmopathy. There was fall in the mean score for ocular movements, corneal and optic nerve function but it did not reach significance after treatment. Electromagnetic field therapy has no useful effect on visual signs and eye movements in two patients who had had the illness more than two years. CONCLUSIONS: Localised pulsed electromagnetic field procedures can be recommended, together with other methods of conservative treatment of endocrine ophthalmopathy.

AI evidence extraction

At a glance
Study type
Other
Effect direction
mixed
Population
Patients with endocrine ophthalmopathy
Sample size
14
Exposure
therapeutic pulsed electromagnetic field (electromagnetic spectacles)
Evidence strength
Very low
Confidence: 74% · Peer-reviewed: yes

Main findings

In 14 patients with endocrine ophthalmopathy, pulsed electromagnetic field therapy reduced scores for soft tissue involvement and proptosis. Mean scores for ocular movements, corneal state, and optic nerve function decreased but were not statistically significant. The therapy had no useful effect on visual signs and eye movements in two patients with illness duration longer than two years.

Outcomes measured

  • eye signs
  • proptosis
  • ocular movements
  • visual sensitivity (static automatic perimetry)
  • soft tissue involvement score
  • corneal state score
  • optic nerve function score

Limitations

  • Small sample size (14 patients)
  • Frequency/dose parameters of the pulsed electromagnetic field not reported in abstract
  • Study design details (randomization/blinding) not described in abstract
  • Control group described (12 controls) but comparative results vs controls not reported in abstract
  • Duration of illness appears to modify response
  • but only noted for two patients
View raw extracted JSON
{
  "study_type": "other",
  "exposure": {
    "band": null,
    "source": "therapeutic pulsed electromagnetic field (electromagnetic spectacles)",
    "frequency_mhz": null,
    "sar_wkg": null,
    "duration": null
  },
  "population": "Patients with endocrine ophthalmopathy",
  "sample_size": 14,
  "outcomes": [
    "eye signs",
    "proptosis",
    "ocular movements",
    "visual sensitivity (static automatic perimetry)",
    "soft tissue involvement score",
    "corneal state score",
    "optic nerve function score"
  ],
  "main_findings": "In 14 patients with endocrine ophthalmopathy, pulsed electromagnetic field therapy reduced scores for soft tissue involvement and proptosis. Mean scores for ocular movements, corneal state, and optic nerve function decreased but were not statistically significant. The therapy had no useful effect on visual signs and eye movements in two patients with illness duration longer than two years.",
  "effect_direction": "mixed",
  "limitations": [
    "Small sample size (14 patients)",
    "Frequency/dose parameters of the pulsed electromagnetic field not reported in abstract",
    "Study design details (randomization/blinding) not described in abstract",
    "Control group described (12 controls) but comparative results vs controls not reported in abstract",
    "Duration of illness appears to modify response, but only noted for two patients"
  ],
  "evidence_strength": "very_low",
  "confidence": 0.74,
  "peer_reviewed_likely": "yes",
  "keywords": [
    "pulsed electromagnetic field",
    "PEMF",
    "endocrine ophthalmopathy",
    "Graves' ophthalmopathy",
    "proptosis",
    "ocular movements",
    "electromagnetic spectacles"
  ],
  "suggested_hubs": [
    {
      "slug": "therapeutic-pemf",
      "weight": 0.9,
      "reason": "Study evaluates pulsed electromagnetic field therapy as a treatment."
    }
  ]
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.

NNEMF synthesis

Synthesis pending.

Original record: rfsafe.org paper 4090

The effect of pulsed electromagnetic field on patients with endocrine ophthalmopathy. · Non-native EMF